# Relay Therapeutics, Inc.: Form 8-K, filed Jan 8, 2024

- Company: [Relay Therapeutics, Inc.](/companies/rlay.md) (CIK 1812364)
- Form: 8-K
- Filed: 2024-01-08
- Accepted by EDGAR: Jan 8, 2024, 07:05 ET
- Period: 2024-01-08
- Accession: 0000950170-24-002682
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1812364/000095017024002682/rlay-20240108.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1812364/000095017024002682/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1812364/000095017024002682/rlay-20240108.htm

Filed Jan 8, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-002682. Last ingested by Listed: Nov 4, 2026, 17:16 ET. No prices; not investment advice.